Facial Hair Reduction Using Intense Pulsed Light (IPL) & Alexandrite Laser

Sponsor
NHS Greater Glasgow and Clyde (Other)
Overall Status
Unknown status
CT.gov ID
NCT01461694
Collaborator
(none)
35
1
2
16
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the efficacy of the IPL system 650advance handpiece with the alexandrite laser for the purposes of female facial hair reduction

Condition or Disease Intervention/Treatment Phase
  • Device: Intense Pulsed Light (IPL)
  • Device: Alexandrite Laser
Phase 2/Phase 3

Detailed Description

This is a randomised (splitface)controlled trial, comparing the use of the Intense Pulsed Light (IPL) system 650 advance handpiece against the Alexandrite Laser for the purposes of female facial hair reduction. Previous studies have shown that the alexandrite laser is superior to IPL in achieving hair reduction. A new handpiece (Lynton, Lumina 650 advance) available for the IPL system is designed to further optimise its use in removing female facial hair (particularly those hair colours previously unresponsive to treatment). This study will compare the alexandrite laser to the IPL system using the new handpiece. This may lead to improvements in the treatment of female patients with male pattern facial hair. Female patients referred to our facial hair reduction service will be recruited to this study. 1/2 their face will be treated with IPL and 1/2 with alexandrite laser. Each participant will receive 6 full treatments at approximately 6 weekly intervals. Participants will be asked to fill in a satisfaction questionnaire and have clinical photographs taken pre treatment and at 1 and 3months post final treatment. All treatments will be carried out in our dedicated laser suite at Glasgow Royal Infirmary.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
35 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Intense Pulsed Light System 650 Advance Hand-Piece and Alexandrite Laser for Female Facial Hair Reduction
Study Start Date :
Nov 1, 2011
Anticipated Primary Completion Date :
Mar 1, 2013
Anticipated Study Completion Date :
Mar 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: IPL

Half face treated with IPL

Device: Intense Pulsed Light (IPL)
Half Face Treated with IPL

Active Comparator: Alexandrite Laser

Half face treated with Alexandrite Laser

Device: Alexandrite Laser
Half face treated with Alexandrite Laser

Outcome Measures

Primary Outcome Measures

  1. Change in total Hair Count measurement at 1month post final treatment from baseline [Baseline and 1 month]

    Pre Treatment hair count assessed using videomicroscopy as baseline. Post final treatment hair counts will be measured again at 1month to assess if there has been a reduction in total hair count from pre-treatment

  2. Change in total hair count at 3months post final treatment from baseline [Baseline and 3months post final treatment]

    Pre Treatment hair count assessed using videomicroscopy as baseline. Post final treatment hair counts will be measured again at 3months to assess if there has been a reduction in total hair count from pre-treatment

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Female Patients

  • Minimum age 16years old

  • Fitzpatrick skin types I-III

  • Significant facial hair.

Exclusion Criteria:
  • Fitzpatrick skin types IV-VI

  • Age less than 16years old

  • Males

  • No visible facial hair growth

  • Use of electrolysis or depilatory creams 6weeks prior to treatment

  • Active acnes

  • Current coldsore

  • Previous facial hair removal with laser or IPL in past 12 months

  • Sun tanned skin

Contacts and Locations

Locations

Site City State Country Postal Code
1 Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary Glasgow United Kingdom G4 0SF

Sponsors and Collaborators

  • NHS Greater Glasgow and Clyde

Investigators

  • Principal Investigator: Adam Gilmour, MBChB, MRCS (Ed), NHS Greater Glasgow & Clyde
  • Study Chair: Iain Mackay, MBChb, MRCS, FRCS (plast), NHS Greater Glasgow & Clyde
  • Study Director: Vivek Sivarajan, MBChB, MRCS, MD, FRCS (Plas), NHS Greater Glasgow & Clyde

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Adam Gilmour, Clinical Laser Research Fellow, NHS Greater Glasgow and Clyde
ClinicalTrials.gov Identifier:
NCT01461694
Other Study ID Numbers:
  • GN11SU380
First Posted:
Oct 28, 2011
Last Update Posted:
May 14, 2012
Last Verified:
May 1, 2012
Keywords provided by Adam Gilmour, Clinical Laser Research Fellow, NHS Greater Glasgow and Clyde
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 14, 2012